SCHEMBL24144012

SCHEMBL24144012

CC(C)Cn1cc(CCN)c2ccc(-c3cncnc3)cc21

nearest known ligand 0.65

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ NR1D1 P20393 19/20 0.65
▸ ICMT O60725 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24143783 0.87 NR1D1 (0.67) NR1D1ICMT
SCHEMBL24142979 0.87 NR1D1 (0.67) NR1D1ICMT
SCHEMBL24144015 0.84 NR1D1 (0.63) NR1D1ICMT
SCHEMBL24143626 0.84 ICMT (0.56) NR1D1ICMT
SCHEMBL24144026 0.83 NR1D1 (0.64) NR1D1ICMT
SCHEMBL24144454 0.83 NR1D1 (0.47) NR1D1ICMT
SCHEMBL24144064 0.82 NR1D1 (0.54) NR1D1ICMT
SCHEMBL24144066 0.82 NR1D1 (0.61) NR1D1ICMT
SCHEMBL24144060 0.81 NR1D1 (0.54) NR1D1ICMT
SCHEMBL24144021 0.81 NR1D1 (0.52) NR1D1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021263278-A1 REV-ERB AGONISTS FOR THE TREATMENT OF TH17-MEDIATED INFLAMMATORY DISORDERS THE SCRIPPS RESEARCH INSTITUTE (US) 2021-12-30 — — WO disclosed
Send feedback